Traders purchased shares of CVS Health Corporation (NYSE:CVS) on weakness during trading on Thursday. $94.21 million flowed into the stock on the tick-up and $57.62 million flowed out of the stock on the tick-down, for a money net flow of $36.59 million into the stock. Of all equities tracked, CVS Health Corporation had the 9th highest net in-flow for the day. CVS Health Corporation traded down ($0.56) for the day and closed at $95.50

A number of research analysts recently commented on CVS shares. Mizuho restated a “buy” rating and issued a $117.00 target price (up from $104.00) on shares of CVS Health Corporation in a research note on Wednesday, May 4th. Royal Bank Of Canada restated an “outperform” rating and issued a $115.00 target price (up from $110.00) on shares of CVS Health Corporation in a research note on Wednesday, May 4th. FBR & Co restated a “buy” rating on shares of CVS Health Corporation in a research note on Saturday, May 14th. Deutsche Bank AG upped their target price on CVS Health Corporation from $99.00 to $105.00 and gave the company a “hold” rating in a research note on Wednesday, June 22nd. Finally, Leerink Swann restated a “buy” rating and issued a $110.00 target price on shares of CVS Health Corporation in a research note on Thursday, May 5th. One analyst has rated the stock with a sell rating, four have issued a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $113.72.

The firm has a market cap of $103.90 billion and a P/E ratio of 21.03. The company has a 50 day moving average price of $95.84 and a 200-day moving average price of $98.38.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings results on Tuesday, May 3rd. The pharmacy operator reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.16 by $0.02. During the same period last year, the firm posted $1.14 EPS. The business had revenue of $43.20 billion for the quarter, compared to analyst estimates of $43.01 billion. CVS Health Corporation’s quarterly revenue was up 18.9% on a year-over-year basis. On average, equities research analysts forecast that CVS Health Corporation will post $5.83 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 1st. Stockholders of record on Thursday, July 21st will be issued a dividend of $0.425 per share. The ex-dividend date is Tuesday, July 19th. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.76%.

In other CVS Health Corporation news, CEO Larry J. Merlo sold 38,247 shares of the company’s stock in a transaction dated Thursday, May 5th. The stock was sold at an average price of $105.00, for a total value of $4,015,935.00. Following the completion of the transaction, the chief executive officer now owns 280,381 shares of the company’s stock, valued at approximately $29,440,005. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Troyen A. Brennan sold 7,517 shares of the company’s stock in a transaction dated Thursday, May 5th. The stock was sold at an average price of $105.00, for a total value of $789,285.00. Following the completion of the transaction, the executive vice president now directly owns 69,601 shares of the company’s stock, valued at approximately $7,308,105. The disclosure for this sale can be found here.

Other institutional investors have recently modified their holdings of the company. Dimensional Fund Advisors LP boosted its position in shares of CVS Health Corporation by 8.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 8,937,908 shares of the pharmacy operator’s stock worth $873,912,000 after buying an additional 689,609 shares during the last quarter. Matarin Capital Management LLC purchased a new position in shares of CVS Health Corporation during the fourth quarter worth about $4,575,000. Birch Hill Investment Advisors LLC boosted its position in shares of CVS Health Corporation by 19.3% in the fourth quarter. Birch Hill Investment Advisors LLC now owns 39,327 shares of the pharmacy operator’s stock worth $3,845,000 after buying an additional 6,355 shares during the last quarter. Dorsey & Whitney Trust CO LLC boosted its position in shares of CVS Health Corporation by 5.9% in the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 13,178 shares of the pharmacy operator’s stock worth $1,289,000 after buying an additional 732 shares during the last quarter. Finally, Stephens Inc. AR boosted its position in shares of CVS Health Corporation by 7.0% in the fourth quarter. Stephens Inc. AR now owns 52,478 shares of the pharmacy operator’s stock worth $5,131,000 after buying an additional 3,411 shares during the last quarter.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.